Proteomics Analyses for the Global Proteins in the Brain Tissues of Different Human Prion Diseases*
Qi Shi,Lina Chen,Baoyun Zhang,Kang Xiao,Wei Zhou,Cao Chen,Xiaomei Zhang,Chan Tian,Chen Gao,Jing Wang,Jun Han,Xiao‐Ping Dong
DOI: https://doi.org/10.1074/mcp.m114.038018
IF: 7.381
2015-01-01
Molecular & Cellular Proteomics
Abstract:Proteomics changes of brain tissues have been described in different neurodegenerative diseases including Alzheimer's disease and Parkinson's disease. However, the brain proteomics of human prion disease remains less understood. In the study, the proteomics patterns of cortex and cerebellum of brain tissues of sporadic Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD were analyzed with isobaric tags for relative and absolute quantitation combined with multidimensional liquid chromatography and MS analysis, with the brains from three normal individuals as controls. Global protein profiling, significant pathway, and functional categories were analyzed. In total, 2287 proteins were identified with quantitative information both in cortex and cerebellum regions. Cerebellum tissues appeared to contain more up- and down-regulated proteins (727 proteins) than cortex regions (312 proteins) of Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD. Viral myocarditis, Parkinson's disease, Alzheimer's disease, lysosome, oxidative phosphorylation, protein export, and drug metabolism-cytochrome P450 were the most commonly affected pathways of the three kinds of diseases. Almost coincident biological functions were identified in the brain tissues of the three diseases. In all, data here demonstrate that the brain tissues of Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD have obvious proteomics changes at their terminal stages, which show the similarities not only among human prion diseases but also with other neurodegeneration diseases. This is the first study to provide a reference proteome map for human prion diseases and will be helpful for future studies focused on potential biomarkers for the diagnosis and therapy of human prion diseases. Proteomics changes of brain tissues have been described in different neurodegenerative diseases including Alzheimer's disease and Parkinson's disease. However, the brain proteomics of human prion disease remains less understood. In the study, the proteomics patterns of cortex and cerebellum of brain tissues of sporadic Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD were analyzed with isobaric tags for relative and absolute quantitation combined with multidimensional liquid chromatography and MS analysis, with the brains from three normal individuals as controls. Global protein profiling, significant pathway, and functional categories were analyzed. In total, 2287 proteins were identified with quantitative information both in cortex and cerebellum regions. Cerebellum tissues appeared to contain more up- and down-regulated proteins (727 proteins) than cortex regions (312 proteins) of Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD. Viral myocarditis, Parkinson's disease, Alzheimer's disease, lysosome, oxidative phosphorylation, protein export, and drug metabolism-cytochrome P450 were the most commonly affected pathways of the three kinds of diseases. Almost coincident biological functions were identified in the brain tissues of the three diseases. In all, data here demonstrate that the brain tissues of Creutzfeldt-Jakob disease, fatal familial insomnia, and G114V genetic CJD have obvious proteomics changes at their terminal stages, which show the similarities not only among human prion diseases but also with other neurodegeneration diseases. This is the first study to provide a reference proteome map for human prion diseases and will be helpful for future studies focused on potential biomarkers for the diagnosis and therapy of human prion diseases. Human prion diseases, also named human transmissible spongiform encephalopathies (TSEs) 1The abbreviations used are:TSEstransmissible spongiform encephalopathiesADAlzheimer's diseasePDParkinson's diseasesCJDsporadic Creutzfeldt–Jakob diseaseFFIfatal familial insomniagCJDG114V genetic CJDiCJDiatrogenic CJDvCJDvariant CJDGSSGerstmann–Sträussler–Scheinker diseaseiTRAQIsobaric tags for relative and absolute quantitationLCliquid chromatographyPrPprion proteinGOGene OntologyPSWperiodic sharp-wavesEEGelectroencephalogramMRIMagnetic resonance imagingCSFCerebrospinal fluidBCAbicinchoninic acidTEABtetraethylammonium bicarbonateSCXstrong cation exchangeHPLChigh performance liquid chromatographyMALDI-TOF/TOFmatrix-assisted laser desorption/ionization time-of-flight/time-of-flightHCDhigher collision energy dissociationCIDcollision induce dissociationNCEnormalized collision energyKEGGKyoto Encycloppedia of Genes and GenomesALSAmyotrophic lateral sclerosisTGNtrans-Golgi network. 1The abbreviations used are:TSEstransmissible spongiform encephalopathiesADAlzheimer's diseasePDParkinson's diseasesCJDsporadic Creutzfeldt–Jakob diseaseFFIfatal familial insomniagCJDG114V genetic CJDiCJDiatrogenic CJDvCJDvariant CJDGSSGerstmann–Sträussler–Scheinker diseaseiTRAQIsobaric tags for relative and absolute quantitationLCliquid chromatographyPrPprion proteinGOGene OntologyPSWperiodic sharp-wavesEEGelectroencephalogramMRIMagnetic resonance imagingCSFCerebrospinal fluidBCAbicinchoninic acidTEABtetraethylammonium bicarbonateSCXstrong cation exchangeHPLChigh performance liquid chromatographyMALDI-TOF/TOFmatrix-assisted laser desorption/ionization time-of-flight/time-of-flightHCDhigher collision energy dissociationCIDcollision induce dissociationNCEnormalized collision energyKEGGKyoto Encycloppedia of Genes and GenomesALSAmyotrophic lateral sclerosisTGNtrans-Golgi network., are fatal neurodegenerative disorders, including Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker disease (GSS), and fatal familial insomnia (FFI). These various subtypes of human TSEs differed with each other in the aspects of clinical symptoms, neuropathology, and genetics, but all eventually undergo fatal consequence (1Liberski P.P. Historical overview of prion diseases: a view from afar.Folia Neuropathol. 2012; 50: 1-12PubMed Google Scholar). The conversion of prion protein (PrP), coded by the PRNP gene, from its cellular isoform PrPC to its pathogenic isoform PrPSc through a post-translational process is considered the etiology of these diseases (2Colby D.W. Prusiner S.B. Prions.Cold Spring Harb. Perspect. Biol. 2011; 3: a006833Crossref PubMed Scopus (400) Google Scholar). Human TSEs can be also etiologically classified as sporadic, such as sporadic CJD (sCJD), genetic or familial, such as genetic CJD (gCJD), GSS, and FFI, and acquired, such as iatrogenic CJD (iCJD) and variant CJD (vCJD). During the long-term pathogenesis of human TSEs, besides of accumulation of PrPSc in brain tissues, numerous brain proteins, which are involved in many different biological processes and pathways, have been described to be abnormally changed (3Shi Q. Jing Y.Y. Wang S.B. Chen C. Sun H. Xu Y. Gao C. Zhang J. Tian C. Guo Y. Ren K. Dong X.P. PrP octarepeats region determined the interaction with caveolin-1 and phosphorylation of caveolin-1 and Fyn.Med. Microbiol. Immunol. 2013; 202: 215-227Crossref PubMed Scopus (14) Google Scholar, 4Guo Y. Gong H.S. Zhang J. Xie W.L. Tian C. Chen C. Shi Q. Wang S.B. Xu Y. Zhang B.Y. Dong X.P. Remarkable reduction of MAP2 in the brains of scrapie-infected rodents and human prion disease possibly correlated with the increase of calpain.PLoS One. 2012; 7: e30163Crossref PubMed Scopus (25) Google Scholar, 5Gong H.S. Guo Y. Tian C. Xie W.L. Shi Q. Zhang J. Xu Y. Wang S.B. Zhang B.Y. Chen C. Liu Y. Dong X.P. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).Int. J. Mol. Med. 2012; 30: 569-578Crossref PubMed Scopus (7) Google Scholar). Recently, the global transcriptional profiles in the brain tissues of some kinds of human TSEs, for example, sCJD, gCJD, and FFI have been reported with the help of high throughput microarray technique (6Tian C. Liu D. Sun Q.L. Chen C. Xu Y. Wang S.B. Zhang B.Y. Chen C. Liu Y. Dong X.P. Comparative analysis of gene expression profiles between cortex and thalamus in Chinese fatal familial insomnia patients.Mol. Neurobiol. 2013; 48: 36-48Crossref PubMed Scopus (25) Google Scholar, 7Tian C. Liu D. Chen C. Xu Y. Gong H.S. Chen C. Shi Q. Zhang B.Y. Han J. Dong X.P. Global transcriptional profiling of the postmortem brain of a patient with G114V genetic Creutzfeldt-Jakob disease.Int. J. Mol. Med. 2013; 31: 676-688Crossref PubMed Scopus (15) Google Scholar). However, the global changes of proteins in the brain tissues, which are definitely important for understanding the pathogenesis of the disease and providing the clues for the disease diagnosis and therapy, remains seldom addressed. transmissible spongiform encephalopathies Alzheimer's disease Parkinson's disease sporadic Creutzfeldt–Jakob disease fatal familial insomnia G114V genetic CJD iatrogenic CJD variant CJD Gerstmann–Sträussler–Scheinker disease Isobaric tags for relative and absolute quantitation liquid chromatography prion protein Gene Ontology periodic sharp-waves electroencephalogram Magnetic resonance imaging Cerebrospinal fluid bicinchoninic acid tetraethylammonium bicarbonate strong cation exchange high performance liquid chromatography matrix-assisted laser desorption/ionization time-of-flight/time-of-flight higher collision energy dissociation collision induce dissociation normalized collision energy Kyoto Encycloppedia of Genes and Genomes Amyotrophic lateral sclerosis trans-Golgi network. transmissible spongiform encephalopathies Alzheimer's disease Parkinson's disease sporadic Creutzfeldt–Jakob disease fatal familial insomnia G114V genetic CJD iatrogenic CJD variant CJD Gerstmann–Sträussler–Scheinker disease Isobaric tags for relative and absolute quantitation liquid chromatography prion protein Gene Ontology periodic sharp-waves electroencephalogram Magnetic resonance imaging Cerebrospinal fluid bicinchoninic acid tetraethylammonium bicarbonate strong cation exchange high performance liquid chromatography matrix-assisted laser desorption/ionization time-of-flight/time-of-flight higher collision energy dissociation collision induce dissociation normalized collision energy Kyoto Encycloppedia of Genes and Genomes Amyotrophic lateral sclerosis trans-Golgi network. The rapid development of proteomics technologies in the past decade allows scientists to be able to define the global protein expression profiles in specific physical or pathological statuses, which are usually not fulfilled by conventional molecular biological technologies (8Otto A. Becher D. Schmidt F. Quantitative Proteomics in the field of Microbiology.Proteomics. 2014; 14: 547-565Crossref PubMed Scopus (57) Google Scholar). Isobaric tags for relative and absolute quantitation (iTRAQ) combined with multidimensional liquid chromatography (LC) and MS analysis is a widely accepted quantitative proteomics that allows a single MS analysis with multiple samples, leading to significant reduction of experimental errors generated from individual experiments (9Martinez-Esteso M.J. Casado-Vela J. Selles-Marchart S. Pedreno M.A. Bru-Martinez R. Differential plant proteome analysis by isobaric tags for relative and absolute quantitation (iTRAQ).Methods Mol. Biol. 2014; 1072: 155-169Crossref PubMed Scopus (16) Google Scholar). The approach allows for sample multiplexing, which can be up to eight-plex at the same time. iTRAQ is particularly powerful when applied on a subfraction of the proteome, thereby increasing the possibility of identifying less abundant proteins (10Evans C. Noirel J. Ow S.Y. Salim M. Pereira-Medrano A.G. Couto N. Pandhal J. Smith D. Pham T.K. Karunakaran E. Zou X. Biggs C.A. Wright P.C. An insight into iTRAQ: where do we stand now?.Anal. Bioanal. Chem. 2012; 404: 1011-1027Crossref PubMed Scopus (242) Google Scholar). All these advantages allow the method to reduce chemical noise and improve quantification accuracy, in addition to improving statistical analysis and augmenting data confidence. To investigate the global protein alterations in the brain tissues of human TSEs, the postmortem cortex and cerebellum tissues from Chinese patients with sCJD, FFI, and G114V gCJD were profiled with iTRAQ analysis, using normal Chinese brain tissues as control. Total 2287 proteins were identified in all of the tested brain samples. In the context of three human TSEs, 161 and 151 proteins were commonly up-regulated and down-regulated in the cortex region, whereas 348 and 379 proteins were commonly up-regulated and down-regulated in the cerebellum region, respectively. FFI had less protein changes than sCJD or G114V gCJD, both in cortex and cerebellum. The commonly impaired pathways among three human prion diseases were Parkinson's disease (PD), Alzheimer's disease (AD), oxidative phosphorylation, and drug metabolism-cytochrome P450. GO (Gene Ontology) analysis revealed that the top five affected biological functions among sCJD, FFI, and G114V gCJD were exactly the same. The similarity and dissimilarity among three human TSEs were discussed in detail. Usage of the stored human brain samples in the China CJD Surveillance System has been approved by the Research Ethics Committee of National Institute for Viral Disease Control and Prevention, China CDC. Human cortex and cerebellum samples collected from the patients with definitely diagnosed sCJD, FFI, or G114V gCJD were enrolled in this study. Meanwhile, the brain tissues from three Chinese individuals that died from accidents were used as normal controls including a 50 year-old man, a 63 year-old man, and a 42-year-old woman. All of them did not have a history of neurological symptoms and chronic disease. The sCJD patient was an 80-year-old man with progressive disturbance of consciousness. One month later, he developed obvious akinetic mutism and inactivity, and subsequently many other symptoms appeared such as alalia, apathy, drowsiness, and pyramidal symptoms. Typical periodic sharp-waves (PSW) were detected in electroencephalogram (EEG). Magnetic resonance imaging (MRI) did not reveal a specific abnormality. Cerebrospinal fluid (CSF) 14–3-3 protein was not performed. The patient died 13 months after onset. Neuropathological assays revealed extensive spongiform degeneration and PrPSc deposits. Western blot identified type I PrPSc in brain tissues. PRNP sequencing analysis did not find any nucleotide exchange. Polymorphism of codon 129 was Met/Met homology. The clinical, genetic, neuropathological, and PrPSc molecular features of three cases of FFI (11Shi X.H. Han J. Zhang J. Shi Q. Chen J.M. Xia S.L. Xie Z.Q. Shen X.J. Shan B. Lei Y.J. Shi S. Zhou W. Zhang B.Y. Gao C. Liu Y.H. Song J. Guo Y.J. Wang D.X. Xu B.L. Dong X.P. Clinical, histopathological, and genetic studies in a family with fatal familial insomnia.Infect. Genet. Evol. 2010; 10: 292-297Crossref PubMed Scopus (30) Google Scholar, 12Shi Q. Chen C. Gao C. Tian C. Zhou W. Zhang B. Han J. Dong X.P. Clinical and familial characteristics of ten chinese patients with fatal family insomnia.Biomed. Environ. Sci. 2012; 25: 471-475PubMed Google Scholar) and one case of G114V gCJD were described in detail in our previous work (13Shi Q. Zhang B.Y. Gao C. Han J. Wang G.R. Chen C. Tian C. Dong X.P. The diversities of PrP(Sc) distributions and pathologic changes in various brain regions from a Chinese patient with G114V genetic CJD.Neuropathology. 2012; 32: 51-59Crossref PubMed Scopus (17) Google Scholar). The main clinical features of the enrolled cases were summarized in Table I.Table IComparison of the main clinical features of the five human TSE patientsCase No.GederAge at onset (y)Family historyForemost symptomsOther signs and symptomsBlood pressure (mmHg)Progressive sympathetic symptomsCSF 14-3-3EEG (PSW*)MRITime of Diagnosis after onset(m)Duration of illness (m)Excessive sweatingSalivationMinor evening pyrexiaWeight losssCJDM80NoProgressive consciousness disturbanceAlalia, apathetic, drowsiness, pyramidal system165/90NoNoNoNoND+-113FFI1M45YesSleep disturbance, sympathetic symptomsInsomnia, dysautonomia, motor Abnormalities145/95YesYesYesYesND-Nor210FFI2F26YesSleep DisturbanceInsomnia, dysautonomia, myoclonus142/98YesYesYesYesND-Nor114FFI3M55YesSleep disturbance, fidgetInsomnia, diaphoresis, hyperthermia, memory loss145/95YesYesNoYes+-Nor28G114VF47YesProgressive dementia, tiredness, lethargyDifficulty in communication, progressive dementia and emotional labilityNoNoNoNo---12.5 Open table in a new tab Brain region samples of parietal lobe and cerebellum were homogenized 1:10 in PBS buffer (137 mm NaCl, 2.7 mm KCl, 10 mm Na2HPO4, 2 mm KH2PO4, pH7.4) according to the protocol described elsewhere (14Zhang J. Chen L. Zhang B.Y. Han J. Xiao X.L. Tian H.Y. Li B.L. Gao C. Gao J.M. Zhou X.B. Ma G.P. Liu Y. Xu C.M. Dong X.P. Comparison study on clinical and neuropathological characteristics of hamsters inoculated with scrapie strain 263K in different challenging pathways.Biomed. Environ. Sci. 2004; 17: 65-78PubMed Google Scholar). Tissue debris was removed with low speed centrifugation at 2000 × g for 10 min and the supernatants were collected. The protein concentration was determined by bicinchoninic acid (BCA) method and the samples were stored at −80 °C for further study. SDS-PAGE was performed to verify the protein quality and concentration. One hundred micrograms of each protein sample was combined with different volumes of tetraethylammonium bicarbonate (TEAB) with 0.1% SDS to equal volume level followed by treatment with trypsin (3.3 μg trypsin/100 μg total protein). The proteins in TEAB were digested with trypsin at 37 °C for 24 h and then another 1 μg trypsin was added in the proteins and digested at 37 °C for another 12 h. The solvent was removed using a SpeedVac. The iTRAQ labeling procedure was performed following the manual provided in the iTRAQ labeling kit (Applied Biosystems, Foster City, CA). The digested samples were dissolved in 30 μl of 50% TEAB together with 70 μl of isoprotocol and labeled with the iTRAQ reagents according to the protocol of the eight-plex iTRAQ labeling kit, including iTRAQ 113–119 and 121. The iTRAQ-labeled products were then pooled and subjected to strong cation exchange (SCX) fractionation. The processes of protein fractionation by HPLC and protein identification by nano RP HPLC and mass spectrometry were performed at Beijing Institute of Genomics, Chinese Academy of Science, based on a fixed methodology published previously (15Chen Z. Wen B. Wang Q. Tong W. Guo J. Bai X. Zhao J. Sun Y. Tang Q. Lin Z. Lin L. Liu S. Quantitative proteomics reveals the temperature-dependent proteins encoded by a series of cluster genes in thermoanaerobacter tengcongensis.Mol. Cell. Proteomics. 2013; 12: 2266-2277Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar). To separate the peptides, two different HPLC approaches were adopted, high-pH RP and strong cation exchange (SCX). In the high-pH RP HPLC procedure, the peptides were loaded onto a RP column (Luna C18, 4.6 mm inner diameter × 250 mm length, Phenomenex, Los Angeles, CA), and eluted by step linear elution program, 0–10 min equilibrated in 100% solution A (2% ACN and 20 mm NH4FA, pH 10), 10–15 min fast elution from 0–12% of solution B (80% ACN and 20 mm NH4FA, pH 10), 15–50 min linear elution from 12–56% of solution B; and 50–55 min washing elution from 56–80% of solution B. In the SCX HPLC procedure, the peptides were loaded onto a SCX column (Luna SCX, 4.6 mm × 250 mm, Phenomenex), and eluted by a step linear elution program, 0–10 min equilibrated in buffer A (25% ACN, 20 mm KCl, and 10 mm KH2PO4, pH 3.0), 10–15 min fast elution from 0–5% of buffer B (25% ACN, 1 m KCl, and 10 mm KH2PO4, pH3.0), 15–50 min linear elution from 5–30% of solution B; and 50–55 min washing elution from 30–80% of solution B. All the HPLC procedures were manipulated in a Prominence HPLC system with the flow rate at 1.0 ml/min and the peptides were monitored at 214 nm. The fractioned peptides were collected at one tube/min during the linear elution period. The eluted fractions were dried in a vacuum concentrator and then dissolved with 0.1% formic acid prior to reverse-phase nLC-tandem mass spectrometry. The peptide contents in the collected fractions were first evaluated by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI-TOF/TOF) MS (Bruker Daltonics, Billerica, MA), and the fractions were further pooled to average the peptide content. The eluted fractions were delivered onto a nano RP column (5-μm Hypersil C18, 75 μm × 150 mm, Thermo Fisher Scientific, Waltham, MA) mounted in a Prominence Nano HPLC system (Ultimate3000, Dionex) and were eluted with acetonitrile (ACN) gradient from 5–40% containing 0.1% formic acid, for 95 min at 400 nl/min. The elution products were directly entered Q-Exactive MS (Thermo Fisher Scientific), setting in positive ion mode and data-dependent manner with full MS scan from 350–2000 m/z, full scan resolution at 70,000, MS/MS scan resolution at 17,500. MS/MS scan with minimum signal threshold 1E+5, isolation width at 2 Da. To evaluate the performance of this mass spectrometry on the iTRAQ labeled samples, higher collision energy dissociation (HCD) for MS/MS acquisition modes was employed. To optimize the MS/MS acquisition efficiency of HCD, normalized collision energy (NCE) was systemically examined 28% and stepped 20%. The raw MS/MS data were converted into MGF format by Thermo Fisher Proteome Discoverer 1.3 (Thermo Fisher Scientific) and the exported MGF files were searched by Mascot 2.3.0 search algorithm (Matrix Science, Boston, MA) against the Uniprot_human database (the time/date of fasta file was Wed Mar 03 23:26:45 2010 and the number of sequences for taxonomy was 20,266 (Homo sapiens)) and an automatic decoy database search was performed. The parameters in Mascot were set for peptide searching, including trypsin as the digestion enzyme, cysteine carbamidomethylation as a fixed modification. iTRAQ eight-plex on the N-terminal residue, iTRAQ eight-plex on tyrosine (Y), iTRAQ eight-plex on lysine (K), Gln-Pyro-Glu (N-term Q), and oxidation on methionine (M) as variable modification. The precursor mass tolerance was set to 15 ppm for precursor ions and 20 mmu for fragment ions. Also, several parameters in Mascot were set for peptide analysis, including the number of distinct peptides assigned for each protein given as “unique” and “peptides”; the coverage of each protein assigned given as “coverage” (supplemental Table S1). The quantification measurement for each peptide and protein was illustrated as the ratio of diseased sample to normal control one, both in the cortex and cerebellum, showing as “sCJD/Nor(Cortex), FFI/Nor(Cortex), G114V/Nor(Cortex), sCJD/Nor(Cerebellum), FFI/Nor(Cerebellum), and G114V/Nor(cerebellum).” Based on the published data (15Chen Z. Wen B. Wang Q. Tong W. Guo J. Bai X. Zhao J. Sun Y. Tang Q. Lin Z. Lin L. Liu S. Quantitative proteomics reveals the temperature-dependent proteins encoded by a series of cluster genes in thermoanaerobacter tengcongensis.Mol. Cell. Proteomics. 2013; 12: 2266-2277Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar) and standard operating procedures (SOP) for iTRAQ-based proteomics in Beijing Institute of Genomics, Chinese Academy of Science, the prerequisites to acquire the significant changed proteins between the brains of human prion diseases and normal control were set up as following. First, a qualified protein for quantitative analysis should have at least one unique peptide labeled with iTRAQ. Second, false discovery rate (FDR) <1% was adopted for all the peptides. Third, the median of unique peptides was used as analysis method for protein ratio type, correction of isotope impurities and normalization of intensity median was considered for judging the differential proteome. The proteins whose p value <0.05 were considered the believed proteins. Finally, the proteins with 1.2-fold changes (>1.20 increased or <0.83 decreased) relative to the normal control were considered as the differential expressed ones based on the published reference (16Ren Y. Hao P. Dutta B. Cheow E.S. Sim K.H. Gan C.S. Lim S.K. Sze S.K. Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies.Mol. Cell. Proteomics. 2013; 12: 485-498Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar, 17Pierce A. Unwin R.D. Evans C.A. Griffiths S. Carney L. Zhang L. Jaworska E. Lee C.F. Blinco D. Okoniewski M.J. Miller C.J. Bitton D.A. Spooncer E. Whetton A.D. Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases.Mol. Cell. Proteomics. 2008; 7: 853-863Abstract Full Text Full Text PDF PubMed Scopus (215) Google Scholar) and the fold changes in protein abundance were defined as the median ratio of all significantly matched spectra with tag signals. Functional analysis of the data set was done using the Ingenuity GO (Gene Ontology) and Pathway Knowledge Base (Ingenuity Systems, Redwood City, CA, www.ingenuity.com). The functional analysis identified biological functions and/or diseases that were most significant to the data set. The analysis was done against the Ingenuity Knowledge Base. Fischer's exact test was used to calculate a p value determining the probability that each biological function and/or disease assigned to that data set is because of chance alone. Canonical pathway analysis identified the pathways from the Ingenuity Pathway Knowledge Base that were most significant to the data set. The significance of the association between the data set and the canonical pathways was measured (1) by the ratio of the number of proteins from the data set that map to the canonical pathway divided by the total number of proteins that map to the canonical pathway and (2) by Fisher's exact test (see above). The focus genes from the two short lists were overlaid onto a global molecular network developed from information contained in the Ingenuity Pathway Knowledge Base. This generated networks based on the connectivity of the individual proteins. At the same time, protein cluster and the assignment of differentially expressed genes were generated. The data were processed with SPSS 16.0 statistics software; descriptive data were expressed as median (range) for continuous variables and as percent for categorical variables. Analysis of continuous variables was done using Mann-Whitney U test, and that of categorical variables was compared using the Chi-square test. A mean value and standard error of multiple data points were used to represent the final result. Student's t test was used in statistical analysis of the data between two groups. To screen the potential difference in brain protein expressions among human prion diseases and normal control, stored postmortem brain tissues of the cortex and cerebellum regions of the patients with sCJD, FFI, G114V gCJD, and normal control were separately subjected into iTRAQ based proteomic study. Considering we utilized an established algorithm for analyzing iTRAQ data (15Chen Z. Wen B. Wang Q. Tong W. Guo J. Bai X. Zhao J. Sun Y. Tang Q. Lin Z. Lin L. Liu S. Quantitative proteomics reveals the temperature-dependent proteins encoded by a series of cluster genes in thermoanaerobacter tengcongensis.Mol. Cell. Proteomics. 2013; 12: 2266-2277Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar), we did not set up the paralleled controls. Prior to the trypsin digestion, all eight brain extracts were evaluated by a SDS-PAGE, which revealed reliable protein integrity (supplemental Fig. S1A). After digestion with trypsin and labeling with iTRAQ separately, all tested samples were pooled for peptide fractionation and identification. The data of MS/MS for digested peptides searched in the Uniprot_human showed most of the digested peptides distributed at the range between 10 and 20 amino acids, reflecting the high-efficiency trypsin digestion (supplemental Fig. S1B). In total, 256,139 MS/MS spectra were achieved, among them 61,050 were matched spectra. 2287 proteins, elicited from 14,534 unique peptides were identified with quantitative information both in cortex and cerebellum brain regions and all the proteins were identified with 95% confidence interval by the Peptide Prophet Algorithm (supplemental Table S1). The annotated spectra for some selected proteins (20 most up- and down-regulated proteins in cortex and 20 in cerebellum) among 2287 identified ones were showed as supplemental Table S2. Using the standards of 1.2-, 1.5-, and 2.0-fold change, the potential differentially expressing proteins in each disease were separately counted. The exact numbers of the up- and down-regulated proteins in cortex and cerebellum tissues from the groups of sCJD, FFI, and G114V gCJD were shown in Fig. 1A. The numbers of 1.2-, 1.5-, and 2.0-fold changed proteins in cortical regions were 1178, 403, and 117 in sCJD, 878, 235, and 74 in FFI, 1314, 537 and 183 in G114V gCJD, whereas those in cerebella regions were 1412, 671, and 158 in sCJD, 1356, 622, and 221 in FFI, 1503, 765, and 316 in G114V gCJD, respectively. For exploring the potential changes in proteomic profiles among the different human prion diseases maximally, we used the proteins that were 1.2-fold increased or decreased as the differential expressing proteins in further analyses. As shown in Fig. 1A and Table II, the numbers of the changed proteins (< or > 1.2-fold change) in the cerebellum tissues of three prion diseases were significantly higher (p = 0.039) than that of the individual cortex regions. More numbers of the changed proteins were identified in the brains of G114V gCJD and sCJD regardless of cortex or cerebellum, whereas FFI contained remarkably less changed protei
What problem does this paper attempt to address?
-
Brain microglia were activated in sporadic CJD but almost unchanged in fatal familial insomnia and G114V genetic CJD
Qi Shi,Wu-Ling Xie,BaoYun Zhang,Li-Na Chen,Yin Xu,Ke Wang,Ke Ren,Xiao-Mei Zhang,Cao Chen,Jin Zhang,Xiao-Ping Dong
DOI: https://doi.org/10.1186/1743-422X-10-216
IF: 5.916
2013-01-01
Virology Journal
Abstract:Background Microglial activations have been described in different subtypes of human prion diseases such as sporadic Creutzfeldt-Jakob disease (CJD), variant CJD, Kuru and Gerstmann-Sträussler-Scheinker disease (GSS). However, the situation of microglia in other genetic prion diseases such as fatal familial insomnia (FFI) and familial CJD remains less understood. The brain microglia was evaluated comparatively between the FFI, G114V and sCJD cases in the study. Methods Specific Western blots, immunohistochemical and immunofluorescent assays were used to detect the changes of microglia and ELISA tests were used for levels of inflammatory cytokines. Results Western blots, immunohistochemical and immunofluorescent assays illustrated almost unchanged microglia in the temporal lobes of FFI and G114V gCJD, but obviously increased in those of sCJD. The Iba1-levels maintained comparable in six different brain regions of FFI and G114V cases, including thalamus, cingulate gyrus, frontal cortex, parietal cortex, occipital cortex and temporal cortex. ELISA tests for inflammatory cytokines revealed significantly up-regulated IL-1β, IL-6 and TNF-α in the brain homogenates from sCJD, but not in those from FFI and G114V gCJD. Conclusion Data here demonstrates silent brain microglia in FFI and G114V gCJD but obviously increased in sCJD, which reflects various pathogenesis of different human prion diseases subtypes.
-
Different Expression Patterns of Ck2 Subunits in the Brains of Experimental Animals and Patients with Transmissible Spongiform Encephalopathies
Jian-Ming Chen,Chen Gao,Qi Shi,Bing Shan,Yan-Jun Lei,Chen-Fang Dong,Run An,Gui-Rong Wang,Bao-Yun Zhang,Jun Han,Xiao-Ping Dong
DOI: https://doi.org/10.1007/s00705-008-0084-z
IF: 2.685
2008-01-01
Archives of Virology
Abstract:To address the possible alteration of casein kinase 2 (CK2) in transmissible spongiform encephalopathies (TSEs), the levels and patterns of CK2 in the brain tissues of hamsters or C57BL mice inoculated intracerebrally with scrapie agents 263K or 139A were evaluated by Western blots, followed by quantitative analysis. Specific semi-quantitative RT-PCR for evaluating the mRNA transcripts of CK2 subunits was performed in parallel. Compared with normal animals, the levels of CK2α and CK2β in the brains of infected hamsters and mice were significantly decreased, regardless of which scrapie agent was. However, the expression of CK2α′ or CK2α′/CK2α′′ in the animals infected with agents 263K or 139A was considerably increased. Furthermore, decreases of CK2α and CK2β and increases of CK2α′/CK2α′′ were observed in cerebella homogenates from one familial Creutzfeldt-Jakob disease (fCJD) case and one fatal familial insomnia (FFI) case. These results suggest that alterations of CK2 subunits in brains are illness-correlative phenomena in TSEs and indicate a potential linkage of CK2 changes with the pathogenesis of prion diseases.
-
Remarkable Reduction of MAP2 in the Brains of Scrapie-Infected Rodents and Human Prion Disease Possibly Correlated with the Increase of Calpain
Yan Guo,Han-Shi Gong,Jin Zhang,Wu-Ling Xie,Chan Tian,Cao Chen,Qi Shi,Shao-Bin Wang,Yin Xu,Bao-Yun Zhang,Xiao-Ping Dong
DOI: https://doi.org/10.1371/journal.pone.0030163
IF: 3.7
2012-01-01
PLoS ONE
Abstract:Microtubule-associated protein 2 (MAP2) belongs to the family of heat stable MAPs, which takes part in neuronal morphogenesis, maintenance of cellular architecture and internal organization, cell division and cellular processes. To obtain insight into the possible alteration and the role of MAP2 in transmissible spongiform encephalopathies (TSEs), the MAP2 levels in the brain tissues of agent 263K-infected hamsters and human prion diseases were evaluated. Western blots and IHC revealed that at the terminal stages of the diseases, MAP2 levels in the brain tissues of scrapie infected hamsters, a patient with genetic Creutzfeldt-Jakob disease (G114V gCJD) and a patient with fatal familial insomnia (FFI) were almost undetectable. The decline of MAP2 was closely related with prolonged incubation time. Exposure of SK-N-SH neuroblastoma cell line to cytotoxic PrP106-126 peptide significantly down-regulated the cellular MAP2 level and remarkably disrupted the microtubule structure, but did not alter the level of tubulin. Moreover, the levels of calpain, which mediated the degradation of a broad of cytoskeletal proteins, were significantly increased in both PrP106-126 treated SK-N-SH cells and brain tissues of 263K prion-infected hamsters. Our data indicate that the decline of MAP2 is a common phenomenon in TSEs, which seems to occur at an early stage of incubation period. Markedly increased calpain level might contribute to the reduction of MAP2.
-
Reduction of Protein Kinase MARK4 in the Brains of Experimental Scrapie Rodents and Human Prion Disease Correlates with Deposits of PrP(Sc).
Han-Shi Gong,Yan Guo,Chan Tian,Wu-Ling Xie,Qi Shi,Jin Zhang,Yin Xu,Shao-Bin Wang,Bao-Yun Zhang,Cao Chen,Yong Liu,Xiao-Ping Dong
DOI: https://doi.org/10.3892/ijmm.2012.1025
IF: 5.314
2012-01-01
International Journal of Molecular Medicine
Abstract:Microtubule affinity-regulating kinase 4 (MARK4) belongs to a family of kinases that are able to actively phosphorylate the neuronal microtubule-associate proteins (MAPs), such as tau, MAP2 and the ubiquitous MAP4. Abnormal changes in tubulin and the profiles of tau have been previously reported in the human brain and animal transmissible spongiform encephalopathies (TSEs), which may be associated with abnormal alterations of various cellular kinases. To elucidate the possible role of MARK4 in TSE pathogenesis, the MARK4 levels in the brain tissues of scrapie-infected rodents and human prion diseases were evaluated using western blotting and immunohistochemical assays. The results revealed that at terminal stages of the diseases, MARK4 levels in the brain tissues of the scrapie 263K-infected hamsters, 139A-infected mice and a case of Creutzfeldt-Jakob disease (CJD, G114V gCJD) correlated with amounts of PrP(Sc) deposits that were almost undetectable. On the other hand MARK4 signals were noticeable in the brain tissues of a fatal familial insomnia (FFI) patient without PrP(Sc). The reduction of MARK4 was closely related to the prolonged incubation times. These results could be reproduced in SK-N-SH and PC12 cell lines after being exposed to the synthetic peptide PrP106-126. Accordingly, the levels of phosphorylated tau at Ser262 (p-tau262) in cultured cells exposed to PrP106-126, or the ratios of p-tau262/total tau in the brain tissues of 263K-infected hamsters were also significantly decreased. According to our data there is a correlation between a TSE pathological-associated decline of MARK4 in the brain tissues with the deposits of PrP(Sc). Reduction of MARK4 will result in abnormalities of tau phosphorylation, and possibly induce further detachment of microtubules and hinder microtubule transportation.
-
Comparison of the Pathologic and Pathogenic Features in Six Different Regions of Postmortem Brains of Three Patients with Fatal Familial Insomnia
Wu-Ling Xie,Qi Shi,Sheng-Li Xia,Bao-Yun Zhang,Han-Shi Gong,Shao-Bin Wang,Yin Xu,Yan Guo,Chan Tian,Jin Zhang,Bian-Li Xu,Yong Liu,Xiao-Ping Dong
DOI: https://doi.org/10.3892/ijmm.2012.1194
IF: 5.314
2012-01-01
International Journal of Molecular Medicine
Abstract:Fatal familial insomnia (FFI) is an autosomal dominant prion disease clinically characterized by rapidly progressive insomnia, prominent autonomic alterations and behavioral disturbance. The D178N mutation of the prion protein gene (PRNP) on chromosome 20 in conjunction with methionine at codon 129 is a molecular feature. Although the neuropathological characteristics of FFI are well documented, the neuropathologic and pathogenic features of FFI patients remain poorly understood. Six brain regions of postmortem brains from 3 FFI patients were examined using immunohistochemistry, western blot analyses and quantitative real-time PCR. In all 3 brain specimens, reactive astrogliosis was found to be more severe in the thalamus than in the cortex regions. Western blot analyses showed that all three brains expressed PrP, but only 2 were associated with significantly weak proteinase K (PK) resistance. However, the conformational stabilities of PrPSc in the 3 FFI brains were significantly weaker than those presented in a G114V genetic Creutzfeldt-Jakob disease (gCJD) case. Immunohistochemistry and western blot analyses showed comparable amounts of neuron-specific enolase (NSE)-positive stained cells and NSE protein among the different regions in the three brains. In addition, the transcriptional levels of glial fibrillary acidic protein (GFAP) and NSE-specific mRNAs were coincident with the expression of these proteins. In conclusion, in the present study, we described the detailed regional neuropathology of FFI cases.
-
Changes of Tau Profiles in Brains of the Hamsters Infected with Scrapie Strains 263 K or 139 A Possibly Associated with the Alteration of Phosphate Kinases
Gui-Rong Wang,Song Shi,Chen Gao,Bao-Yun Zhang,Chan Tian,Chen-Fang Dong,Rui-Min Zhou,Li,Cao Chen,Jun Han,Xiao-Ping Dong
DOI: https://doi.org/10.1186/1471-2334-10-86
IF: 3.7
2010-01-01
BMC Infectious Diseases
Abstract:Abstract Background Phospho-tau deposition has been described in a rare genetic human prion disease, Gerstmann-Sträussler-Scheinker syndrome, but is not common neuropathological picture for other human and animal transmissible spongiform encephalopathies (TSEs). This study investigated the possible changes of tau and phosphorylated tau (p-tau, at Ser396, Ser404, and Ser202/Thr205) in scrapie experimental animals. Methods The profiles of tau and p-tau (p-tau, at Ser396, Ser404, and Ser202/Thr205) in the brain tissues of agents 263K- or 139A-infected hamsters were evaluated by Western blots and real-time PCR. Meanwhile, the transcriptional and expressive levels of GSK3β and CDK5 in the brains were tested. Results The contents of total tau and p-tau at Ser202/Thr205 increased, but p-tau at Ser396 and Ser404 decreased at the terminal stages, regardless of scrapie strains. Transcriptional levels of two tau isoforms were also increased. Additionally, it showed higher CDK5, but lower GSK3β transcriptional and expressive levels in the brains of scrapie-infected animals. Analysis of brain samples collected from different times after inoculated with agent 263 K revealed that the changes of tau profiles and phosphate kinases were time-relative events. Conclusion These data suggest that changes of profiles of p-tau at Ser396, Ser404 and Ser202/Thr205 are illness-correlative phenomena in TSEs, which may arise of the alteration of phosphate kinases. Alteration of tau, p-tau (Ser396, Ser404, and Ser202/Thr205), GSK3β and CDK5 were either intermediate or consequent events in TSE pathogenesis and proposed the potential linkage of these bioactive proteins with the pathogenesis of prion diseases.
-
Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway
Qi Shi,Qin-Qin Song,Peng Sun,Jin Zhang,Juan Song,Li-Na Chen,Kang Xiao,Shao-Bin Wang,Ya-Zhou Zhang,Gong-Qi Li,Lin-Jun Sheng,Bao-Dong Wang,Ming-Zhi Lu,Jun Han,Xiao-Ping Dong
DOI: https://doi.org/10.1007/s12035-013-8560-1
IF: 5.682
2013-01-01
Molecular Neurobiology
Abstract:The 14-3-3 proteins are a family of highly homologous and ubiquitously expressed isoforms that are involved in a wide variety of physiological processes. 14-3-3 have showed actively molecular interaction with PrP and positive 14-3-3 is frequently observed in the cerebrospinal fluid (CSF) samples of the patients with sporadic Creutzfeldt–Jakob disease (CJD). However, the alterations of 14-3-3 in the brain tissues of patients with prion diseases remain little addressed. To address the possible change of brain 14-3-3 during prion infection, we firstly tested the levels of 14-3-3 in the brain tissues of scrapie agent 263 K infected hamsters. Obviously decreased 14-3-3 were observed in the samples of the infected animals, showing time-dependent reduction in the incubation period, while the amounts of S -nitrosylated 14-3-3 were increased in the brains collected at the late stage. A low level of 14-3-3 was also observed in the scrapie infectious cell line SMB-S15, accompanied with up-regulated Bax and down-regulated Bcl-2. Moreover, we found that treatment of PrP106–126 on the cultured cells decreased the cellular 14-3-3 and caused translocations of cellular Bax to the membrane fractions. Knockdown of cellular 14-3-3 sensitized the cultured cells to the challenge of PrP106–126. These data illustrate that significant down-regulation of brain 14-3-3 levels during prion infection may not only be a scenario of the terminal consequence of interacting with abnormal PrP Sc but may also participate in the pathogenesis of neuronal damage.
-
Global Protein Differential Expression Profiling of Cerebrospinal Fluid Samples Pooled from Chinese Sporadic CJD and non-CJD Patients
Cao Chen,Di Xiao,Wei Zhou,Qi Shi,Hui-Fang Zhang,Jin Zhang,Chan Tian,Jian-Zhong Zhang,Xiao-Ping Dong
DOI: https://doi.org/10.1007/s12035-013-8519-2
IF: 5.682
2013-01-01
Molecular Neurobiology
Abstract:The shotgun proteomic based on the approach of tandem mass tag (TMT) labeling has received increasing attention for neuroproteomics analysis and becomes an effective tool for the identification and quantification of a large number of proteins for the purpose of revealing key proteins involved in the neuronal dysfunction and an inflammatory response associated with neurodegenerative disorders. To assess the potential expression difference of proteins in cerebrospinal fluids (CSF) between Creutzfeldt–Jakob disease (CJD) and non-CJD patients, the pooled CSF samples from 39 Chinese probable sporadic CJD (sCJD) patients and from 52 non-CJD cases were comparably analyzed with the methodology of TMT labeling and RP-RP-UPLC-MS/MS. Totally, 437 possible proteins were identified in the tested CSF specimen, among them, 49 proteins with 95 % confidence interval. Differential assays showed among those 49 CSF proteins, 12 were upregulated and 13 were downregulated significantly in the sCJD compared to non-CJD. The most affected pathway of the differential expression proteins in CSF of sCJD was complement and coagulation cascade. Western blots for six selected changed proteins in the pooled CSF samples revealed the similar altering profiles in the groups of sCJD and non-CJD as proteomics. Furthermore, CSF samples from 24 CJD patients and 24 non-CJD patients were randomly selected and subjected individually into the Western blots of an increased protein (phosphoglycerate mutase 1) and a decreased one (alpha-1-antichymotrysin), which also confirmed the altering tendency of these identified proteins. Those data indicate that proteomic assay of CSF is a powerful technique not only for selection of the potential biomarkers for the development of diagnostic tool of CJD but also for supplement of useful scientific clues for understanding the CSF homeostasis during the pathogenesis of prion diseases.
-
Abnormally Upregulated Αb-Crystallin Was Highly Coincidental with the Astrogliosis in the Brains of Scrapie-Infected Hamsters and Human Patients with Prion Diseases
Ke Wang,Jin Zhang,Yin Xu,Ke Ren,Wu-Ling Xie,Yu-E Yan,Bao-Yun Zhang,Qi Shi,Yong Liu,Xiao-Ping Dong
DOI: https://doi.org/10.1007/s12031-013-0057-x
2013-01-01
Journal of Molecular Neuroscience
Abstract:αB-crystallin is a member of the small heat shock protein family constitutively presenting in brains at a relatively low level. To address the alteration of αB-crystallin in prion disease, the αB-crystallin levels in the brains of scrapie agent 263 K-infected hamsters were analyzed. The levels of αB-crystallin were remarkably increased in the brains of 263 K-infected hamsters, showing a time-dependent manner along with incubation time. Immunohistochemical (IHC) and immunofluorescent (IFA) assays illustrated more αB-crystallin-positive signals in the regions of the cortex and thalamus containing severe astrogliosis. Double-stained IFA verified that the αB-crystallin signals colocalized with the enlarged glial fibrillary acidic protein-positive astrocytes, but not with neuronal nuclei-positive cells. IHC and IFA of the serial brain sections of infected hamsters showed no colocalization and correlation between PrPSc deposits and αB-crystallin increase. Moreover, increased αB-crystallin deposits were observed in the brain sections of parietal lobe of a sporadic Creutzfeldt–Jakob disease (sCJD) case, parietal lobe and thalamus of a G114V genetic CJD case, and thalamus of a fatal family insomnia (FFI) case, but not in a parietal lobe of FFI where only very mild astrogliosis was addressed. Additionally, the molecular interaction between αB-crystallin and PrP was only observed in the reactions of recombinant proteins purified from Escherichia coli, but not either in that of brain homogenates or in that of the cultured cell lysates expressing human PrP and αB-crystallin. Our data indicate that brain αB-crystallin is abnormally upregulated in various prion diseases, which is coincidental with astrogliosis. Direct interaction between αB-crystallin and PrP seems not to be essential during the pathogenesis of prion infection.
-
[Alternations of Tau Protein and Its Phosphorylated Profiles in the Experimental Hamsters Infected by Scrapie Agents 263K and 139A].
Gui-rong Wang,Song Shi,Chen Gao,Bao-yun Zhang,Chan Tian,Chen-fang Dong,Rui-min Zhou,Xiao-li Li,Cao Chen,Xiao-ping Dong
DOI: https://doi.org/10.3321/j.issn:1000-8721.2009.03.008
2009-01-01
Abstract:In human prion diseases, phosphorylated-tau deposition has been described in a rare genetic form, Gerstmann-Straussler-Scheinker disease, but is not considered part of the neuropathological picture of Creutzfeldt-Jakob disease. To investigate the possible changes of tau and phosphorylated tau (Ser396/Ser404) in transmissible spongiform encephalopathies (TSEs), the expressions and transcriptions of above biological factors in the brain tissues of 263K- and 139A-infected hamsters were evaluated by Western blots and Real Time PCR, respectively, followed by quantitative analyses of immunoblot images and relative transcriptional levels compared with normal animals. The contents of total tau increased, but phosphorylated tau at Ser396 and Ser404 decreased, regardless of the types of scrapie agents and clinical incubations. Transcriptions of two tau isoforms were also markedly increased. These findings suggested that dephosphorylation of tau at Ser396/Ser404 was a illness-correlative phenomenon in TSEs. Alterations of tau and phosphorylated tau (Ser396/Ser404) were either intermediate or consequent events in TSE pathogenesis and proposed the potential linkage of these bioactive proteins with the pathogenesis of prion diseases.
-
The Diversities of PrP(Sc) Distributions and Pathologic Changes in Various Brain Regions from a Chinese Patient with G114V Genetic CJD.
Qi Shi,Bao-Yun Zhang,Chen Gao,Jun Han,Gui-Rong Wang,Cao Chen,Chan Tian,Xiao-Ping Dong
DOI: https://doi.org/10.1111/j.1440-1789.2011.01237.x
2011-01-01
Neuropathology
Abstract:Human genetic Creutzfeldt-Jakob disease (gCJD; one of the prion diseases) is caused by point mutations and insertions in the prion protein gene (PRNP). Previously we have reported a Chinese gCJD case with a substitution of valine (V) for glycine (G) at codon 114. To investigate the detailed pathogenic and pathologic characteristics of G114V gCJD, 10 different brain regions were thoroughly analyzed. PrP-specific Western blots and immunohistochemical (IHC) assays identified larger amounts of PrP(Sc) in the regions of brain cortex. Assays of the transcriptions of PrP-specific mRNA by RT-PCR and real-time PCR showed comparable levels in 10 brain regions. In line with the distribution of PrP(Sc) , typical vacuolations in brains, markedly in four cortex regions, were detected. Contrast to the distributing features of spongiform and of PrP(Sc) , massive gliosis was detected in all brain regions by GFAP-specific IHC tests. Moreover, two-dimensional gel immunoblots found three major sets of PrP(Sc) spots, indicating that PrP(Sc) in brain tissues was a mixture of molecules with different biochemical properties. The data here provide the pathogenic and neuropathological features of G114V gCJD.
-
Human Prion Disease with a G114V Mutation and Epidemiological Studies in a Chinese Family: a Case Series
Jing Ye,Jun Han,Qi Shi,Bao-Yun Zhang,Gui-Rong Wang,Chan Tian,Chen Gao,Jian-Min Chen,Cun-Jiang Li,Zheng Liu,Xian-Zhang Li,Lai-Zhong Zhang,Xiao-Ping Dong
DOI: https://doi.org/10.1186/1752-1947-2-331
2008-01-01
Journal of Medical Case Reports
Abstract:Introduction Transmissible spongiform encephalopathies are a group of neurodegenerative diseases of humans and animals. Genetic Creutzfeldt-Jakob diseases, in which mutations in the PRNP gene predispose to disease by causing the expression of abnormal PrP protein, include familial Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia. Case presentation A 47-year-old Han-Chinese woman was hospitalized with a 2-year history of progressive dementia, tiredness, lethargy and mild difficulty in falling asleep. On neurological examination, there was severe apathy, spontaneous myoclonus of the lower limbs, generalized hyperreflexia and bilateral Babinski signs. A missense mutation (T to G) was identified at the position of nt 341 in one PRNP allele, leading to a change from glycine (Gly) to valine (Val) at codon 114. PK-resistant PrP Sc was detected in brain tissues by Western blotting and immunohistochemical assays. Information on pedigree was collected notably by interviews with family members. A further four suspected patients in five consecutive generations of the family have been identified. One of them was hospitalized for progressive memory impairment at the age of 32. On examination, he had impairment of memory, calculation and comprehension, mild ataxia of the limbs, tremor and a left Babinski sign. He is still alive. Conclusion This family with G114V inherited prion disease is the first to be described in China and represents the second family worldwide in which this mutation has been identified. Three other suspected cases have been retrospectively identified in this family, and a further case with suggestive clinical manifestations has been shown by gene sequencing to have the causal mutation.
-
Proteomic Analyses for the Global S-Nitrosylated Proteins in the Brain Tissues of Different Human Prion Diseases
Li-Na Chen,Qi Shi,Bao-Yun Zhang,Xiao-Mei Zhang,Jing Wang,Kang Xiao,Yan Lv,Jing Sun,Xiao-Dong Yang,Cao Chen,Wei Zhou,Jun Han,Xiao-Ping Dong
DOI: https://doi.org/10.1007/s12035-015-9440-7
IF: 5.682
2015-01-01
Molecular Neurobiology
Abstract:Human prion diseases are fatal neurodegenerative disorders characterized by neuronal damage in brain. Protein S-nitrosylation, the covalent adduction of a NO to cysteine, plays a role in human brain biology, and brain dysfunction is a prominent feature of prion disease, yet the direct brain targets of S-nitrosylation are largely unknown. We described the first proteomic analysis of global S-nitrosylation in brain tissues of sporadic Creutzfeldt–Jakob disease (sCJD), fatal familial insomnia (FFI), and genetic CJD with a substitution of valine for glycine at codon 114 of the prion protein gene (G114V gCJD) accompanying with normal control with isobaric tags for relative and absolute quantitation (iTRAQ) combined with a nano-HPLC/Q-Exactive mass spectrometry platform. In parallel, we used several approaches to provide quality control for the experimentally defined S-nitrosylated proteins. A total of 1509 S-nitrosylated proteins (SNO-proteins) were identified, and data are available via ProteomeXchange with identifier PXD002813. The cerebellum tissues appeared to contain more commonly differentially expressed SNO-proteins (DESPs) than cortex of sCJD, FFI, and gCJD. Three selected SNO-proteins were verified by Western blots, consistent with proteomics assays. Gene ontology analysis showed that more up-regulated DESPs were involved in metabolism, cell cytoskeleton/structure, and immune system both in the cortex and cerebellum, while more down-regulated ones in both regions were involved in cell cytoskeleton/structure, cell-cell communication, and miscellaneous function protein. Pathway analysis suggested that systemic lupus erythematosus, pathogenic Escherichia coli infection, and extracellular matrix-receptor interaction were the most commonly affected pathways, which were identified from at least two different diseases. Using STRING database, the network of immune system and cell cytoskeleton and structure were commonly identified in the context of the up-regulated and down-regulated DESPs, respectively, both in the cortex and cerebellum. Our study thus have implications for understanding the molecular mechanisms of human prion diseases related to abnormal protein S-nitrosylation and pave the way for future studies focused on potential biomarkers for the diagnosis and therapy of human prion diseases.
-
Rare genetic Creutzfeldt-Jakob disease with T188K mutation: analysis of clinical, genetic and laboratory features of30 Chinese patients
Qi Shi,Wei Zhou,Cao Chen,Kang Xiao,Yuan Wang,Chen Gao,Xiao-Ping Dong
DOI: https://doi.org/10.1136/jnnp-2016-314868
2017-01-01
Abstract:Genetic human prion diseases include genetic or familial Creutzfeldt-Jakob disease (gCJD or fCJD), fatal familial insomnia (FFI) and Gerstmann-Straussler-Scheinker syndrome (GSS). T188K gCJD was first described in Germany in 2000.1 The first Chinese patient with T188K gCJD was identified in 2009.2 By March 2016, 30 Chinese cases with T188K gCJD were identified and genetically diagnosed via national CJD surveillance programme. T188K gCJD is now the second-most frequent genetic prion disease among Chinese (next to FFI),3 however, is rarely reported in the other countries besides China.All cases with 30 T188K gCJD in this report were Han-Chinese without sibship. The gender ratio (male to female) was 1:0.76. The onset ages of the patients varied from 40 to 85 years old, with the median age of 59 years. More patients (13 cases) were in the group of 50–59 years old, followed by those of 60–69 and 70–79 years old.The interval from onset to reporting to CJD surveillance centre differed from 1 to 9 months (median: 2.5 months). All patients appeared more than one symptom at onset. Progressive dementia was noticed in 2/3 patients (20/30), followed by cerebellum symptoms and walk unstable (12/30), mental (10/30) and extrapyramidal (9/10) symptoms. In the whole clinical courses, progressive dementia was described in 93.3% (28/30) cases. Pyramidal or extrapyramidal dysfunction, myoclonus, visual or cerebellar disturbance and akinetic mutism appeared in 80% (24/30), 60% (18/30), 73.3% (22/30) and 43.3% …
-
Characteristics of Different Types of Prion Diseases - China's Surveillance.
Qi Shi,Chen Cao,Kang Xiao,Wei Zhou,Chen Gao,Liping Gao,Jun Han,Jichun Wang,Xiao-Ping Dong
DOI: https://doi.org/10.46234/ccdcw2022.151
2022-01-01
Abstract:This report briefly described the establishment and implementation of national surveillance for human prion disease (PrD) in China. Reported cases came from Chinese surveillance network for PrD. Immunohistochemistry, Western blot, enzyme-linked immunosorbent assay (ELISA), Polymerase Chain Reaction (PCR), and real-time quaking-induced conversion (RT-QuIC) tests were used for the samples of brain, cerebrospinal fluid (CSF), and blood. Diagnosis standard for the PrDs is based on the National Commission of Health (WS/T 562-2017). The study summarized major epidemiological, clinical and laboratory features of more than 2,100 diagnosed different types of Chinese PrD cases. Sporadic Creutzfeldt-Jacob disease (sCJD) is the predominant type of PrD (88.7%). 19 different genotypes of genetic PrDs (gPrDs) were identified, accounting for about 11.3% of all PrDs, revealing ethno-relationships. No iatrogenic CJD (iCJD) and variant CJD (vCJD) was identified. The characteristics of different types of sCJD in China showed similar features as those reported globally, but gPrDs showed an obvious ethno-relationship.
-
T188K-Familial Creutzfeldt–Jacob Disease, Predominant among Chinese, Has a Reactive Pattern in CSF RT-QuIC Different from D178N-Fatal Familial Insomnia and E200K-Familial CJD
Kang Xiao,Qi Shi,Wei Zhou,Bao-Yun Zhang,Yuan Wang,Cao Chen,Yue Ma,Chen Gao,Xiao-Ping Dong
DOI: https://doi.org/10.1007/s12264-019-00354-z
IF: 5.271
2019-01-01
Neuroscience Bulletin
Abstract:Dear Editor,Human prion diseases consist of sporadic, genetic/familial,and acquired forms. The familial form accounts for 5%–15%of all human prion diseases, including familial Creutzfeldt–Jacob disease （fCJD）, Gerstmann–Stra¨ussler–Scheinker
-
Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of transmissible and rapidly progressive neurodegenerative diseases including Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI) in humans, bovine spongiform encephalopathy (BSE) in cattle, scrapi
KANG XIAO,BAO-YUN ZHANG,XIAO-MEI ZHANG,JING WANG,CAO CHEN,LI-NA CHEN,LV YAN,QI SHI,XIAO-PING DONG
2016-01-01
Abstract:It is well known that the SMB-S15 cell line was originally established by cultures from the brains of mice affected by the Chandler scrapie strain, and this cell line may express PrPSc permanently. However, the infectivity of the S15-derived prions on experimental animals has not yet been well documented. In the present study, the cell lysates of SMB-S15 were intracerebrally inoculated into three different strains of mice, namely C57BL/6, Balb/c and CD1. Prion protein (PRNP) gene sequencing revealed the same encoded PrP proteins in the sequences of amino acids in the three strains of mice, in addition to a synonymous single nucleotide polymorphism (SNP) in CD1 mice. All infected mice developed typical experimental t ransmissible spongiform encephalopathies (TSEs) approximately six months post-infection. The clinical features of three infected mice were comparable. The pathogenic characteristics, such as the electrophoretic and glycosylation profiles and proteinase K (PK) resistance of PrPSc molecules, as well as the neuropathological characteristics, such as spongiform vacuolation, PrPSc deposits in cortex regions, astrogliosis and activated microglia, were also similar in all three strains of infected mice. However, PrPSc deposits in the cerebellums of CD1 mice were significantly fewer, which was linked with the observation that lower numbers of CD1 mice presented cerebellum-associated symptoms. Successive inoculation of the individual strains of mice with brain homogenates from the infected mice also induced typical experimental scrapie. The data in the present study thus confirm that the prion agent in SMB-S15 cells causes stable infectivity in different types of mice with distinct phenotypes after long-term propagation in vitro. The present study also provides further scrapie rodent models, which may be used in further studies.
-
Significant Enhanced Expressions of Aquaporin-1, -4 and -9 in the Brains of Various Prion Diseases
Qi Shi,Yue-Zhang Wu,Xuehua Yang,Kang Xiao,Adalaiti Maimaitiming,Li-Ping Gao,Cao Chen,Chen Gao,Yanjun Guo,Xiao-Ping Dong
DOI: https://doi.org/10.1080/19336896.2019.1660487
2019-01-01
Prion
Abstract:Aquaporins (AQPs) are widely expressed in various types of tissues, among them AQP1, AQP4 and AQP9 are expressed predominately with relatively special distributing features in various brain regions. The aberrant changes of AQP1 and AQP4 have been observed in the brains of Alzheimer disease (AD). To evaluate the underlying alteration of brain AQPs in prion diseases, scrapie strains of 139A, ME7 and S15 infected mice were tested in this study. Western blots revealed markedly increased levels of AQP1, AQP4 and AQP9 in the brain tissues of all tested scrapie-infected mice collected at terminal stage. Analyses of the AQPs levels in the brain tissues collected at different time-points during incubation period showed time-dependent increased in 139A and ME7-infected mice, especially at the middle-late stage. The AQP1 levels also increased in the cortex regions of some human prion diseases, including the patients with sporadic Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI) and G114V genetic CJD (gCJD). Immunohistochemistry (IHC) assays verified that the AQPs-positive cells were astrocyte-like morphologically; meanwhile, numerous various sizes of AQPs-positive particles and dots were also observable in the brain sections of scrapie-infected mice. Immunofluorescent assays (IFAs) illustrated that the signals of AQPs colocalized with those of the GFAP positive proliferative astrocytes, and more interestingly, appeared to overlap also with the signals of PrP in the brains of scrapie-infected mice. Moreover, IHC assays with a commercial doublestain system revealed that distributing areas of AQPs overlapped not only with that of the activated large astrocytes, but also with that of abundantly deposited PrPSc in the brain tissues of scrapie murine models. Our data here propose the solid evidences that the expressions of brain AQP1, AQP4 and AQP9 are all aberrantly enhanced in various murine models of scrapie infection. The closely anatomical association between the accumulated AQPs and deposited PrPSc in the brain tissues indicates that the abnormally increased water channel proteins participate in the pathogenesis of prion diseases.
-
PrP(Sc) of Scrapie 263K Propagates Efficiently in Spleen and Muscle Tissues with Protein Misfolding Cyclic Amplification.
Song Shi,Chen-Fang Dong,Gui-Rong Wang,Xin Wang,Run An,Jian-Ming Chen,Bing Shan,Bao-Yun Zhang,Kun Xu,Qi Shi,Chan Tian,Chen Gao,Jun Han,Xiao-Ping Dong
DOI: https://doi.org/10.1016/j.virusres.2008.12.010
IF: 6.286
2009-01-01
Virus Research
Abstract:Transmissible spongiform encephalopathies (TSEs), or prion diseases, are transmissible neurodegenerative disorders of protein conformation. This group of diseases is caused by infectious agents, termed prions, which can convert normal conformation (PrPC) into misfolded protein (PrPSc). The infectivity of non-neuronal tissues has been wildly addressed, but the propagating features and the biochemical properties of prion generated from these tissues are only partially settled. In this study, utilizing protein misfolding cyclic amplification (PMCA), the in vitro conversion of PrPC into PrPSc in spleen and muscle tissues can be induced by PrPSc produced in vivo. The further propagation of newly formed PrPSc in normal brain and some of the biochemical properties of new PrPSc are similar as the brain-derived prions, implying the naturally infectious pathway of prion from peripheral generation to neuro-invasion. However, compared with the brain-derived PrPSc, the weaker resistance of new PrPSc to some inactivated agents, i.e. sodium hydroxide and thermal inactivation, are observed. Our data provide the reliable evidence that the brain-derived PrPSc can utilize the PrPC from non-neuronal tissues for its propagation. Similarity of the replicative ability in PMCA in vitro and the infectivity in vivo highlights the possibility to use PMCA instead of bioassay to investigate the propagation of prion.
-
A Patient with Creutzfeldt-Jakob Disease with an Insertion of 7 Octa-Repeats in the PRNP Gene: Molecular Characteristics and Clinical Features
Yan-Jun Guo,Xiao-Fan Wang,Jun Han,Bao-Yun Zhang,Wfi-Qin Zhao,Qi Shi,Yan-Zhen Wan,Chen Gao,Ji-Mei Li,De-Xin Wang,Xiao-Ping Dong
DOI: https://doi.org/10.1097/maj.0b013e3181643e50
2008-01-01
Abstract:Background: We evaluated the features of neuropathology, abnormal prion protein (PrP) molecules, and clinical data of a Chinese woman diagnosed with familiar Creutzfeldt-Jakob disease (CJD), having 7 octa-repeats inserted with codon 129 methionine homozygote in the PRNP gene. Methods: Neuropathologic characteristics of the brain were analyzed by hemotoxylin-eosin stain and electronic microscopy. The presence of abnormal PrP in brains was detected by proteinase K and PrP molecules were evaluated by deglycosylation assay. Results: Spongiform degeneration, with diffuse neuronal loss and mild astrocytic gliosis, as well as with profound degeneration of neurons and astrocytes was observed. Proteinase K-resistant PrP was deposited widely in various regions of the brain. Calculation of the glycosylation ratios of proteinase K-resistant PrP molecules identified that the monoglycosyl isomer was predominant. PrP deglycosylation tests allowed for the identification of a predominant 19-kDa PrP signal that represents a partially proteolytic C-terminal segment, a 27-kDa band that represents the full-length wild-type PrP molecule, and a 30-kDa hand that probably corresponds to the full-length mutant PrP molecule. conclusion: Sporadic CJD-like neuropathologic changes and deposits of proteinase K-resistant PrP have been identified in this familiar CJD case with a 168 base pair nucleotide insertion. The clinical features differ from previously reported cases that had 7 octa-repeat insertion, but bear similarities to sporadic CJD.